Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_references_url in Reference URL (approximate match)

Showing 271 - 280 of 332 results

First page
Previous page
Next page
Next page

Duvalgagene Otiparvovec

K24R94BC3K

Status:

Investigational

Source:

INN:duvalgagene otiparvovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/K24R94BC3K

Class:

STRUCTURALLY DIVERSE

SARS-COV2

B6L4N5Z4GH

Status:

Investigational

Source:

NCT04387760: Phase 2 Interventional Completed SARS-CoV 2

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04387760

Class:

STRUCTURALLY DIVERSE

PLASMODIUM FALCIPARUM SPOROZOITE NF54 STRAIN (GAMMA IRRADIATED)

8F73JQB6BY

Status:

Investigational

Source:

NCT03503058: Phase 2 Interventional Completed Malaria

(2022)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03503058

Class:

STRUCTURALLY DIVERSE

AUTOLOGOUS EX VIVO EXPANDED CD4+-ENRICHED LEUKOCYTES TREATED WITH THE DE-METHYLATING AGENT 5-AZA-DEOXYCYTIDINE

B2NUS89036

Status:

Investigational

Source:

NCT02799238: Phase 2 Interventional Completed Glioblastoma

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02799238

Class:

STRUCTURALLY DIVERSE

Plasmodium falciparum

536WV61NML

Status:

Investigational

Source:

NCT03867331: Phase 1 Interventional Completed Malaria,Falciparum

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03867331

Class:

STRUCTURALLY DIVERSE

PSEUDOMONAS AERUGINOSA

Y793W5V55N

Status:

Investigational

Source:

NCT01380808: Phase 2 Interventional Completed Metastatic Breast Cancer

(2011)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01380808

Class:

STRUCTURALLY DIVERSE

CCRF-CEM Cell line

UQE5C46LPZ

Status:

Other

Class:

STRUCTURALLY DIVERSE

Lactobacillus acidophilus W37

7DNG9TKT35

Status:

Other

Class:

STRUCTURALLY DIVERSE

Incilius alvarius venom

M69B5WXJ5Y

Status:

Other

Class:

STRUCTURALLY DIVERSE

ARPE-19 cell line

DNW3UM8W8R

Status:

Other

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

Duvalgagene Otiparvovec

Structurally Diverse

SARS-COV2

Structurally Diverse

PLASMODIUM FALCIPARUM SPOROZOITE NF54 STRAIN (GAMMA IRRADIATED)

Structurally Diverse

AUTOLOGOUS EX VIVO EXPANDED CD4+-ENRICHED LEUKOCYTES TREATED WITH THE DE-METHYLATING AGENT 5-AZA-DEOXYCYTIDINE

Structurally Diverse

Plasmodium falciparum

Structurally Diverse

PSEUDOMONAS AERUGINOSA

Structurally Diverse

CCRF-CEM Cell line

Structurally Diverse

Lactobacillus acidophilus W37

Structurally Diverse

Incilius alvarius venom

Structurally Diverse

ARPE-19 cell line

Showing 271 - 280 of 332 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1